Medical Condition News

RSS

Researchers use molecular diagnostic methods to detect cancer

The ABC Medical Center, located in Mexico City, implemented various molecular diagnostic methods that can detect the genetic alterations in several types of cancer, so they can select a personalized therapy for each patient and direct it against the mutated genes that cause disease.

13 May 2014

People who consume diet rich in resveratrol are likely to develop cardiovascular disease

A study of Italians who consume a diet rich in resveratrol — the compound found in red wine, dark chocolate and berries — finds they live no longer than and are just as likely to develop cardiovascular disease or cancer as those who eat or drink smaller amounts of the antioxidant.

13 May 2014

People with mental health conditions more likely to use nicotine-delivery devices, says study

Researchers at University of California, San Diego School of Medicine report that people living with depression, anxiety or other mental health conditions are twice as likely to have tried e-cigarettes and three times as likely to be current users of the controversial battery-powered nicotine-delivery devices, as people without mental health disorders.

13 May 2014

Researchers identify several target molecules suitable for development of new allergy drugs

Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy.

13 May 2014

Novel molecule prevents symptoms linked with allergen-induced asthma

A new study carried out by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), the Max Planck Institute for Colloids and Interfaces (Germany), the Free University of Berlin (Germany), UC San Diego, and Shinshu University (Japan) has identified a novel molecule that prevents T-cells from orchestrating asthma brought on by allergens.

13 May 2014

Research may offer unique pathway for targeting new therapeutics for addiction treatment

A research team from the Friedman Brain Institute of the Icahn School of Medicine at Mount Sinai has published evidence that shows that subtle changes of inhibitory signaling in the reward pathway can change how animals respond to drugs such as cocaine.

13 May 2014

Researchers use natural molecule to treat type 2 diabetes

Researchers at the Universit- Laval Faculty of Medicine, the Quebec Heart and Lung Institute Research Center, and the Institute of Nutrition and Functional Foods have discovered a natural molecule that could be used to treat insulin resistance and type 2 diabetes.

13 May 2014

Beaumont Children's Hospital wins grant from CureSearch Children's Cancer to help fund therapeutic clinical trials

CureSearch for Children's Cancer has awarded a $20,000 grant to Beaumont Children's Hospital to help fund therapeutic clinical trials.

13 May 2014

Sports Authority, MRA partner to educate public about melanoma

Sports Authority, one of the nation's largest full-line sporting goods retailers, today announced that they have partnered with the Melanoma Research Alliance, the largest private funder of melanoma research, to inform the public about this deadly form of skin cancer and to raise funds to support studies aimed at its treatment and cure. This is the fourth consecutive year Sports Authority has participated in and supported the effort.

12 May 2014

Abeona Therapeutics obtains FDA Orphan Drug Designations for Sanfilippo Syndrome therapies

Abeona Therapeutics, a start-up company created around intellectual property licensed from Nationwide Children's Hospital to develop treatments for Sanfilippo Syndrome Types A and B, has been granted Orphan Drug Designations for its lead investigational therapies by the U.S. Food and Drug Administration Office of Orphan Products Development.

12 May 2014

NPS MedicineWise welcomes ABC’s decision to take down Catalyst program on statins, heart disease

NPS MedicineWise has welcomed the ABC’s ruling — published today — that its Catalyst program aired in October 2013 on statins and heart disease breached its own standards on impartiality.

12 May 2014

Results from Sorin Group's study on Freedom Solo presented at AATS 2014

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, is proud to announce the results of its trial on the Freedom Solo for approval on the US market presented at the 94th Annual Meeting of American Association for Thoracic Surgery in Toronto, Canada.

12 May 2014

NSHOA and Caris Life Sciences collaborate to establish personalized cancer care program

North Shore Hematology Oncology Associates and Caris Life Sciences today announced a collaboration to establish a personalized cancer care program for patients in the greater Long Island area.

12 May 2014

FDA approves Bayer's Kogenate FS antihemophilic factor VIII to prevent bleeding episodes in adults with hemophilia A

Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for Bayer's Kogenate® FS antihemophilic factor VIII (recombinant), for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.

12 May 2014

Jintronix receives clearance from FDA for Jintronix rehabilitation system

Jintronix, a company radically changing how patients rehabilitate from stroke or other injury, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Jintronix rehabilitation system.

12 May 2014

Biochemists identify protein that can slow down growth of brain tumors in mice

Much like using dimmer switches to brighten or darken rooms, biochemists have identified a protein that can be used to slow down or speed up the growth of brain tumors in mice.

12 May 2014

Anti-cancer drug delivery method smuggles drug into cancer cell before triggering release

Biomedical engineering researchers have developed an anti-cancer drug delivery method that essentially smuggles the drug into a cancer cell before triggering its release.

12 May 2014

Cervical cancer rates in US higher than previously believed, particularly among older women

Cervical cancer rates in the United States are higher than previously believed, particularly among 65- to 69-year-old women and African-American women, according to a study led by a researcher at the University of Maryland School of Medicine published in the journal Cancer.

12 May 2014

Researchers reveal how protein acts as brake against pathological growth of heart muscle

Cardiovascular disease remains the number one cause of death in the Western world, with heart failure representing the fastest-growing subclass over the past decade.

12 May 2014

New implantable cuff with 24 electrodes helps reduce high blood pressure

Freiburg researchers develop new method for lowering high blood pressure without side effects. High blood pressure is the greatest health risk worldwide behind smoking and alcohol consumption.

12 May 2014

Medical Condition News

Researchers use molecular diagnostic methods to detect cancer

People who consume diet rich in resveratrol are likely to develop cardiovascular disease

People with mental health conditions more likely to use nicotine-delivery devices, says study

Researchers identify several target molecules suitable for development of new allergy drugs

Novel molecule prevents symptoms linked with allergen-induced asthma

Research may offer unique pathway for targeting new therapeutics for addiction treatment

Researchers use natural molecule to treat type 2 diabetes

Beaumont Children's Hospital wins grant from CureSearch Children's Cancer to help fund therapeutic clinical trials

Sports Authority, MRA partner to educate public about melanoma

Abeona Therapeutics obtains FDA Orphan Drug Designations for Sanfilippo Syndrome therapies

NPS MedicineWise welcomes ABC’s decision to take down Catalyst program on statins, heart disease

Results from Sorin Group's study on Freedom Solo presented at AATS 2014

NSHOA and Caris Life Sciences collaborate to establish personalized cancer care program

FDA approves Bayer's Kogenate FS antihemophilic factor VIII to prevent bleeding episodes in adults with hemophilia A

Jintronix receives clearance from FDA for Jintronix rehabilitation system

Biochemists identify protein that can slow down growth of brain tumors in mice

Anti-cancer drug delivery method smuggles drug into cancer cell before triggering release

Cervical cancer rates in US higher than previously believed, particularly among older women

Researchers reveal how protein acts as brake against pathological growth of heart muscle

New implantable cuff with 24 electrodes helps reduce high blood pressure

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News